Concepedia

Divas Neupane

DN

5

Publications

194

Citations

5

H-Index

2004

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Dartmouth–Hitchcock Medical Center

Divas Neupane is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, antibody engineering, and immunology.

Top concepts

MedicineImmunologyAntibody EngineeringAllergyProteomicsBioanalysisAutoimmunityBiochemistryPharmacologyDrug Analysis

Publications per year

2004–2020

5

Publications

5

DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance

Alexey V. Danilov, Divas Neupane, Archana S. Nagaraja et al. · PLoS ONE · 2011 · 74 citations · Full text

14-3-3σ Modulates Pancreatic Cancer Cell Survival and Invasiveness

Divas Neupane, Murray Korc · Clinical Cancer Research · 2008 · 54 citations · Full text

Regulated proteolysis of the IFNaR2 subunit of the interferon-alpha receptor

Abu Z. M. Saleh, Aaron T Fang, Allison E. Arch et al. · Oncogene · 2004 · 42 citations

Ifnar2 Subunit, Signal Transduction, Protein Function +10

Pharmacokinetic Properties of Humanized IgG1 and IgG4 Antibodies in Preclinical Species: Translational Evaluation

Mohammad Tabrizi, Divas Neupane, Sophia E. Elie et al. · The AAPS Journal · 2019 · 13 citations

Translational Medicine, Igg4 Antibodies, Immunocytochemical Technique +13

A capillary electrophoresis based approach for the identification of anti-drug antibodies against camelid VHH biologics (Nanobodies®)

Derek Wiswell, Divas Neupane, Minchao Chen et al. · Journal of Pharmacological and Toxicological Methods · 2020 · 11 citations

Camelid Vhh Biologics, Capillary Electrophoresis, Medicine +12

Rows per page

1–5 of 5